Central and Mucosal Immunities are Modified by Non Adsorbable Antibiotic Treatment in Uncomplicated Diverticular Disease

Author(s): F. Pandolfi, S. Frosali, L. Petruzziello, E.E. Newton, G. Costamagna.

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 16 , Issue 3 , 2016

Submit Manuscript
Submit Proposal

Abstract:

We review our experience on Rifaximin in uncomplicated diverticular disease. Our data show that a 2 week treatment induces modifications in the immune system: local mucosal lymphocytes with TLR-4 were increased. In the peripheral blood CD103 cells, which increased before treatment, returned to normal values after Rifaximin.

Keywords: Diverticular disease, rifaximin, mucosal immunity, TLR2, TLR4, T-lymphocytes.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 16
ISSUE: 3
Year: 2016
Page: [218 - 221]
Pages: 4
DOI: 10.2174/1389557515666150722104035
Price: $58

Article Metrics

PDF: 14
HTML: 3
EPUB: 1